Market Research Logo

Global Non-invasive Prenatal Testing Market 2017-2021

Global Non-invasive Prenatal Testing Market 2017-2021

About Non-invasive Prenatal Testing

Non-invasive prenatal screening is performed primarily by ultrasonography and serum testing from maternal plasma. Ultrasonography uses the clear tissue behind the infant’s neck to detect genetic defects. A fetus with abnormalities tends to accumulate more fluid. Hence, more clear space is detected behind the neck, which is an indicative measure. Maternal serum screening is a method that involves blood testing in the first and second trimester of the gestation period where specific chemicals such as pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (HCG) are checked.

Technavio’s analysts forecast the global non-invasive prenatal testing market to grow at a CAGR of 16.86% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Non-invasive Prenatal Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • BGI Genomics
  • Illumina
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics
Other prominent vendors
  • Agilent Technologies
  • Berry Genomics
  • F. Hoffman-La Roche
  • LifeCodexx
  • Natera
  • PerkinElmer
Market driver
  • Advantages of non-invasive methods over invasive methods
  • For a full, detailed list, view our report
Market challenge
  • Abortion rate and ethical hurdles
  • For a full, detailed list, view our report
Market trend
  • Increase in acceptance of NIPT
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Non-invasive Prenatal Testing Market 2017-2021

Technavio recognizes the following companies as the key players in the global non-invasive prenatal testing market: BGI Genomics, Illumina, Laboratory Corporation of America Holdings, and Quest Diagnostics.

Other Prominent Vendors in the market are: Agilent Technologies, Berry Genomics, F. Hoffman-La Roche, LifeCodexx, Natera, and PerkinElmer.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increase in acceptance of NIPT. The clinical implementation of NIPT is increasing across the world due to its commercialization and the marketing capabilities of vendors. Within a very short span of time, NIPT has been adopted by physicians across the world. Most physicians include NIPT for routine pregnancy diagnosis.”

According to the report, one driver in the market is advantages of non-invasive methods over invasive methods. The introduction of NIPT in 2011 enabled the safe screening and detection of chromosomal abnormalities in fetuses. Invasive methods of prenatal testing are painful. They could also cause miscarriages. However, advances in genomic sciences and bioinformatic analytical tools have led to the development of NIPT. NIPT reduces the chances of miscarriage, involves less pain, and reduces the number of false-positive results. The fetus is not affected because the fetal DNA used for screening is collected from maternal blood and tested using sequencing.

Further, the report states that one challenge in the market is abortion rate and ethical hurdles. With a rapid increase in prenatal screening using NIPT, there are chances of early fetal abortions. NIPT is widely used to detect genetic defects. However, it is also used to determine the gender of the fetus, which could lead to the termination of pregnancy. Choice about the future of the child, physical and emotional harm to the mother, and societal views are ethical challenges associated with prenatal screening.

Companies Mentioned

BGI Genomics, Illumina, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies, Berry Genomics, F. Hoffman-La Roche, LifeCodexx, Natera, and PerkinElmer.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Overview
      • Table Types of prenatal diagnosis and screening
      • Table Lifecycle of prenatal testing techniques
  • Market landscape
    • Overview
      • Table Comparative analysis of NIPT with other techniques
      • Table Global NIPT market: Overview 2017-2021
    • Market size and forecast
      • Table Global NIPT market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Segmentation by application
    • Overview
      • Table Global NIPT market: Segmentation by application 2016 (% share)
      • Table Global NIPT market: Segmentation by application 2021 (% share)
      • Table Global NIPT market: Segmentation by application 2016-2021 (% share)
    • Trisomy
      • Table Global NIPT by trisomy market 2016-2021 ($ millions)
    • Microdeletions
      • Table Global NIPT by microdeletions market 2016-2021 ($ millions)
    • Others
      • Table Global NIPT by others market 2016-2021 ($ millions)
  • Segmentation by end-user
    • Overview
      • Table Global NIPT market: Segmentation by end-user 2016-2021 (% share)
    • Diagnostic centers
      • Table Global NIPT market by diagnostic centers 2016-2021 ($ millions)
    • Hospitals
      • Table Global NIPT market by hospitals 2016-2021 ($ millions)
  • Segmentation by geography
    • Overview
      • Table Global NIPT market: Segmentation by geography 2016-2021 (% share)
    • Regional comparison
      • Table Global NIPT market: Regional comparison
    • NIPT market in Americas
      • Table NIPT market in Americas 2016-2021($ millions)
      • Table NIPT market in Americas: Year-over-year growth 2017-2021 (%)
    • NIPT market in EMEA
      • Table NIPT market in EMEA 2016-2021 ($ millions)
      • Table NIPT market in EMEA: Year-over-year growth (%) (2017-2021)
    • NIPT market in APAC
      • Table NIPT market in APAC 2016-2021 ($ million)
      • Table NIPT market in APAC: Year-over-year growth 2017-2021 (%)
    • Key leading countries
      • Table Global NIPT market: Key leading countries
    • Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Increase in acceptance of NIPT
    • Increase in genetic counseling
    • Growth of genetic screening programs at births
  • Vendor landscape
    • Competitive scenario
      • Table Global NIPT market: Growth and success factors of vendors
    • Investment opportunities
      • Table Global NIPT market: Investment opportunity mapping
  • Key vendor analysis
    • BGI Genomics
      • Table BGI Genomics: Overview
      • Table BGI Genomics: Strength analysis
      • Table BGI Genomics: Strategy assessment
      • Table BGI Genomics opportunity assessment
    • Illumina
      • Table Illumina: Overview
      • Table Illumina: Strength analysis
      • Table Illumina: Strategy assessment
      • Table Illumina: Opportunity assessment
    • Laboratory Corporation of America Holdings
      • Table Laboratory Corporation of America Holdings: Overview
      • Table Laboratory Corporation of America Holdings: Strength analysis
      • Table Laboratory Corporation of America Holdings: Strategy assessment
      • Table Laboratory Corporation of America Holdings: Opportunity assessment
    • Quest Diagnostics
      • Table Quest Diagnostics Overview
      • Table Quest Diagnostics: Strength analysis
      • Table Quest Diagnostics: Strategy assessment
      • Table Quest Diagnostics: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report